{
    "id": "3403af18-3562-c8de-e063-6294a90ace5d",
    "indications": {
        "text": "lysodren indicated treatment patients inoperable , functional nonfunctional , adrenocortical carcinoma ( acc ) .",
        "doid_entities": [
            {
                "text": "adrenocortical carcinoma (DOID:3948)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3948"
            },
            {
                "text": "carcinoma (DOID:305)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_305"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended initial dose lysodren 2000 mg 6000 mg orally , three four divided doses per day food . ( 2.3 ) titrate lysodren dose achieve plasma level 14 20 mg/l . ( 2.3 ) lysodren lipophilic accumulates adipose tissue . ( 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "lysodren tablets supplied 500 mg white , round , biconvex , scored tablets , bisected one side impressed `` bl `` `` l1 `` side . 100 tablets per bottle : ndc 76336-080-60",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MITOTANE",
            "code": "78E4J5IB5J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6954"
        }
    ],
    "organization": "HRA Pharma Rare Diseases",
    "name": "Lysodren",
    "effectiveTime": "20250430",
    "indications_original": "LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC).",
    "contraindications_original": "The recommended initial dose of LYSODREN is 2000 mg to 6000 mg orally, in three or four divided doses per day with food. ( 2.3 ) Titrate LYSODREN dose to achieve a plasma level of 14 to 20 mg/L. ( 2.3 ) LYSODREN is lipophilic and accumulates in adipose tissue. ( 2.3 )",
    "warningsAndPrecautions_original": "LYSODREN tablets are supplied as 500 mg white, round, biconvex, scored tablets, bisected on one side and impressed with \"BL\" over \"L1\" on the other side.\n                  \n                     100 tablets per bottle: NDC 76336-080-60",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Lysodren",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        }
    ]
}